science
Lower-frequency signal: Viking conquest ahead in obesity?
An expert with 35 years of experience in the obesity field called Viking Therapeutics Inc.’s prospect VK-2735 “among the best that we’ve seen,” and shares (NASDAQ:VKTX) reflected as much, closing Sept. 22 at $40.85, up $10.74, or 35.7%, having traded as high as $41.13.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
I turn up late to meetings to dodge small talk. Am I wrong? - Nature
Google News
Esther Rantzen was utterly unique... the entire nation will miss her energy
Express
Simulating death can reduce people’s fear of dying
The Economist
It may soon be possible to create “mirror life”
The Economist
MI5 Issues Rare Public Alert to Stop Chinese Intelligence Benefiting From UK University Research
International Business Times